eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
abstract:
Original paper

Does COVID-19 determine short- and long-term prognosis in patients with pulmonary embolism? Analysis of data from a pulmonology centre in Świętokrzyskie, Poland

Patrycja Zając
1
,
Karol Kaziród-Wolski
2
,
Janusz Sielski
2
,
Youssef Sleiman
3
,
Magdalena Wolska
4
,
Zbigniew Siudak
2

  1. Rheumatology Department of the Province Hospital, Końskie, Poland
  2. Collegium Medicum, Jan Kochanowski University, Kielce, Poland
  3. Provincial Specialist Hospital, Czerwona Góra, Poland
  4. Outpatient Treatment Facility ”CenterMed”, Kielce, Poland
Medical Studies/Studia Medyczne
DOI: https://doi.org/10.5114/ms.2024.142953
Online publish date: 2024/09/13
View full text Get citation
 
PlumX metrics:
Introduction:
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection has been associated with thrombotic complications, the pathophysiological mechanism of which is complex.

Aim of the research:
To analyse factors influencing the prognosis of patients with pulmonary embolism and COVID-19 (coronavirus disease 2019).

Material and methods:
A retrospective study was conducted on a group of 70 patients with pulmonary embolism and concomitant respiratory system infection. The patients were divided into those with a negative test result for the presence of the SARS-CoV-2 (n = 25) and those with a positive result (n = 45). Clinical and imaging characteristics of both groups were presented. Univariate and multivariable logistic regression analyses were performed to identify predictors of 30-day and 1-year mortality.

Results:
The study revealed that short-term survival did not differ between the COVID (+) and COVID-19 (–) groups (40 (88.9%) vs. 18 (72.0%), p = 0.1), while long-term survival was higher in the COVID-19 (+) group compared to the COVID-19 (–) group (38 (84.4%) vs. 10 (40.0%), p = 0.0001). Factors influencing short-term survival were lymphocyte levels and left-sided intraparenchymal changes on imaging, while long-term survival was influenced by platelet count, INR, respiratory failure, oxygen saturation, fibrous-striated changes on imaging, and subpleural location. Both short- and long-term survival were determined by higher levels of erythrocytes, haemoglobin, longer prothrombin time, and the intensity of oxygen therapy. The only independent predictor of long-term mortality was concomitant neoplastic disease (OR = 29.03 (1.32–640.2); p = 0.03).

Conclusions:
COVID-19 does not independently affect long-term survival in patients with pulmonary embolism.

keywords:

pulmonary embolism, long-term outcome, COVID-19, SARS-CoV2
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.